Market Cap $204.1M
!


Corporate Spotlight
Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight
RAC Accelerates Game-Changing Cancer Drug
Last update - 15.57pm 30/07/2025 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | $1.18 | Day High | $1.19 | Day Low | $1.16 | |||
Daily Volume | 65430 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
4 | $1.17 | 20389 | 4 | $1.20 | 6324 |
Directors & Senior Management
Dr. Sophia Moscovis | Vice President of Operations and Strategy |
Dr. Serge Scrofani | Non-Executive Director |
Mr. Brendan Brown | Chief Financial Officer |
Dr. Daniel Tillett | Chief Executive Officer, Managing Director |
Dr Megan Baldwin | Non-Executive Director |
Dr. Peter Smith | Executive Chairman of the Board |
Dr. Simon Fisher | Vice President - Clinical |
Prof. Michael Kelso | Vice President - Research |
Dr. Marinella Messina | Vice President - Clinical Development |
Dr. Jose Iglesias | Chief Medical Officer |
Mr. Peter Gordon Webse | Company Secretary |
Data source: Refinitiv